183 related articles for article (PubMed ID: 7521827)
1. Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.
Hurley JC
Drugs; 1994 Jun; 47(6):855-61. PubMed ID: 7521827
[No Abstract] [Full Text] [Related]
2. Antiendotoxin monoclonal antibodies for gram-negative sepsis.
Chmel H; Emmanuel G
Clin Infect Dis; 1992 Aug; 15(2):371-2. PubMed ID: 1520771
[No Abstract] [Full Text] [Related]
3. Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA.
Wenzel RP; Andriole VT; Bartlett JG; Batt MD; Bullock WE; Cobbs CG; Light B; Martin MA; Sanford J; Sande MA
Clin Infect Dis; 1992 Apr; 14(4):973-6. PubMed ID: 1482434
[No Abstract] [Full Text] [Related]
4. [A cost-effectiveness analysis of treatment with antiendotoxin monoclonal antibodies in gram-negative sepsis].
Tebas P
Med Clin (Barc); 1993 Dec; 101(19):757-8. PubMed ID: 8289526
[No Abstract] [Full Text] [Related]
5. Centoxin: the full story of its withdrawal.
Andrews PA
Br J Hosp Med; 1993 Apr 7-20; 49(7):517. PubMed ID: 8490693
[No Abstract] [Full Text] [Related]
6. Centoxin: the full story of its withdrawal.
Choyce MQ
Br J Hosp Med; 1993 Apr 7-20; 49(7):517. PubMed ID: 8490694
[No Abstract] [Full Text] [Related]
7. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
Barriere SL; Guglielmo BJ
Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
[TBL] [Abstract][Full Text] [Related]
8. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Gorelick KJ; Chmel H
Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
[TBL] [Abstract][Full Text] [Related]
9. The search for a magic bullet to fight sepsis.
Bone RC
JAMA; 1993 May; 269(17):2266-7. PubMed ID: 8474207
[No Abstract] [Full Text] [Related]
10. Update on monoclonal antibody therapy in the gram-negative sepsis syndrome.
Hecker RB
J Am Osteopath Assoc; 1992 Aug; 92(8):1017-20. PubMed ID: 1429060
[TBL] [Abstract][Full Text] [Related]
11. [Preventive interruption of the administration of HA-1A monoclonal antibody against endotoxin].
Torrabadella de Reynoso P; Trilla A; Salgado A; Ribas J
Med Clin (Barc); 1993 Apr; 100(13):518. PubMed ID: 8479241
[No Abstract] [Full Text] [Related]
12. Antiendotoxin antibodies.
Siegel JP
Ann Intern Med; 1995 Feb; 122(4):315-6. PubMed ID: 7825773
[No Abstract] [Full Text] [Related]
13. Monoclonal antibodies for gram-negative sepsis.
Med Lett Drugs Ther; 1991 Nov; 33(856):103-4. PubMed ID: 1943976
[No Abstract] [Full Text] [Related]
14. Antiendotoxin antibodies: a dead end?
Cross AS
Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
[No Abstract] [Full Text] [Related]
15. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis.
Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ
Crit Care Med; 1992 Jun; 20(6):730-5. PubMed ID: 1597023
[TBL] [Abstract][Full Text] [Related]
16. Antiendotoxin monoclonal antibodies. What future now?
Susla GM; Dew RB
Drug Saf; 1994 Oct; 11(4):215-22. PubMed ID: 7848542
[No Abstract] [Full Text] [Related]
17. [The influence of immunocorrection on the state of the anti-endotoxin immunity in children with systemic inflammatory response syndrome and gram-negative infection].
Pritulo LF
Klin Khir; 2009 May; (5):38-41. PubMed ID: 19957748
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to endotoxin in the management of sepsis.
Fang KC
West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
[TBL] [Abstract][Full Text] [Related]
19. Lessons learned from clinical trials on monoclonal anti-endotoxin antibody.
Weil MH
Arch Intern Med; 1994 Jun; 154(11):1183. PubMed ID: 8203986
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody therapy for gram-negative sepsis: principles, applications, and controversies.
Mehra IV; Gottlieb JE; Nash DB
Pharmacotherapy; 1993; 13(2):128-34. PubMed ID: 8469619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
